These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 411941)

  • 1. FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
    Geil RG; Lamar JK
    J Toxicol Environ Health; 1977 Sep; 3(1-2):179-93. PubMed ID: 411941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The morphologic effects of synthetic reproductive steroids on the mammary gland of rhesus monkeys. Mestranol, ethynerone, mestranol-ethynerone, chloroethynyl norgestrel-mestranol, and anagestone acetate-mestranol combinations.
    Tavassoli FA; Casey HW; Norris HJ
    Am J Pathol; 1988 May; 131(2):213-34. PubMed ID: 3358452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary nodules in beagle dogs administered investigational oral contraceptive steroids.
    Giles RC; Kwapien RP; Geil RG; Casey HW
    J Natl Cancer Inst; 1978 Jun; 60(6):1351-64. PubMed ID: 650701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids.
    Kwapien RP; Giles RC; Geil RG; Casey HW
    J Natl Cancer Inst; 1980 Jul; 65(1):137-44. PubMed ID: 6930510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in estrogen metabolism after chronic oral contraceptive administration in the rhesus monkey.
    Slikker W; Lipe GW; Sziszak TJ; Bailey JR
    Drug Metab Dispos; 1984; 12(2):148-53. PubMed ID: 6144478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and plasma lipids.
    Dhillon MK; Sarkar AK; Gupta AN; Devi PK
    J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral contraceptives on the mammary glands of Rhesus monkeys: a preliminary report.
    Drill VA; Martin DP; Hart ER; McConnell RG
    J Natl Cancer Inst; 1974 May; 52(5):1655-7. PubMed ID: 4208715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid studies in women using combination type of oral contraceptives.
    Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
    J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
    Owen LN; Briggs MH
    Curr Med Res Opin; 1976; 4(5):309-29. PubMed ID: 64332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
    Kistner RW
    Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.